The abnormal activation of NLRP3 inflammasome can lead to a variety of diseases including sterile inflammatory diseases (Abderrazak et al., 2015), diabetes (Luo et al., 2014), and non-alcoholic fatty liver diseases (Lv et al., 2019). Here, NLRP3 is linked to diabetes mellitus.